Bausch and Glenmark announce approval of RYALTRIS in Canada
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
To set up 50 lifestyle modification centres across the UAE in the next 24 months
Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Lenalidomide is used to treat various types of cancers.
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Subscribe To Our Newsletter & Stay Updated